Results 201 to 210 of about 113,779 (376)

Vaccination against COVID-19 in a haemodialysis centre: what is the risk of bleeding complications? [PDF]

open access: gold, 2021
Matthieu Giot   +4 more
openalex   +1 more source

Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes.

open access: yesEuropean Journal of Vascular and Endovascular Surgery, 2017
L. Bylsma   +4 more
semanticscholar   +1 more source

Risk factors for persistent decline in eGFR of Japanese patients with diabetes: Analysis using a large‐scale diabetes registry J‐DREAMS

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims/Introduction This study aimed to identify clinical predictors associated with sustained decline in estimated glomerular filtration rate (eGFR) among Japanese individuals diagnosed with diabetes mellitus. Materials and Methods We conducted a retrospective analysis using J‐DREAMS (Japan Diabetes compREhensive database project based on an ...
Kota Yamada   +5 more
wiley   +1 more source

Clinical Profile and Outcome of Haemodialysis in Patients With COVID-19 – A Single Centre Experience [PDF]

open access: diamond, 2021
Harsh Vardhan   +7 more
openalex   +1 more source

Construction of a prognostic assessment model for diabetic nephropathy based on serum fibrinogen and renal tissue IFTA score

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Objective To explore the association between serum fibrinogen (FIB) and clinicopathological features and renal prognosis in type 2 diabetic nephropathy (T2DN), and develop a web‐based dynamic model to predict renal progression. Methods This paper retrospectively enrolled 173 biopsy‐proven T2DN patients and stratified them by the optimal FIB ...
Lin Ning   +5 more
wiley   +1 more source

Spanish Clinical Guidelines on Vascular Access for Haemodialysis.

open access: yesNefrología, 2017
J. Ibeas   +24 more
semanticscholar   +1 more source

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault   +51 more
wiley   +1 more source

Home - About - Disclaimer - Privacy